Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA

Abstract Background Trastuzumab in combination with chemotherapy is the standard first-line (1L) treatment for HER2+ metastatic gastric cancer (mGC) in the USA. Objective This study characterizes the real-world treatment patterns, healthcare resource use (HRU), and costs in patients with HER2+ mGC p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Afsaneh Barzi (Autor), Feng Lin (Autor), Jinlin Song (Autor), Clara Lam (Autor), Xiaoyu Nie (Autor), Ahmed Noman (Autor), Winghan J. Kwong (Autor)
Formato: Libro
Publicado: Adis, Springer Healthcare, 2023-08-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible